Hemangioendothelioma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
Condition: Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma Intervention: Drug: Tacrolimus ointment Sponsor: West China Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2019 Category: Research Source Type: clinical trials